Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
325
-
Total 13F shares, excl. options
-
35.9M
-
Shares change
-
-196K
-
Total reported value, excl. options
-
$5.42B
-
Value change
-
-$28.5M
-
Put/Call ratio
-
0.77
-
Number of buys
-
157
-
Number of sells
-
-131
-
Price
-
$151.04
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2018
350 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2018.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 325 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.9M shares
of 152M outstanding shares and own 23.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.68M shares), VANGUARD GROUP INC (3.2M shares), BROWN CAPITAL MANAGEMENT LLC (1.99M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.92M shares), Neuberger Berman Group LLC (1.65M shares), BAMCO INC /NY/ (1.52M shares), Mairs & Power INC (1.38M shares), JANUS HENDERSON GROUP PLC (1.32M shares), STATE STREET CORP (992K shares), and Jackson Square Partners, LLC (910K shares).
This table shows the top 325 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.